Several in vitro assays have been developed to evaluate the gastrointestinal absorption of compounds. Our aim was to compare 3 of these methods: 1) the bio-mimetic artificial membrane permeability assay (BAMPA) method, which offers a highthroughput, noncellular approach to the measurement of passive transport; 2) the traditional Caco-2 cell assay, the use of which as a high-throughput tool is limited by the long cell differentiation time (21 days); and 3)
A LTHOUGH BIOLOGICAL EFFICACY is the key issue during the discovery process of active compounds, other factors such as bioavailability are equally important when the action of the ingredient is not limited to the gastrointestinal tract. An efficacious compound must be sufficiently bioavailable to perform its expected activity. The gastrointestinal absorption of an orally administered compound is one of the key factors for its bioavailability. Because absorption potential has become a more important criterion in the discovery process, there is a need for reliable screening methods to assess for compound permeability. 1 Intestinal absorption screening assays should be highly predictive, fast, reliable, cost-effective, and require a small amount of compound. 2, 3 Current approaches include physicochemical models, in silico computational models, in vitro models (cell and tissue based), in situ models of intestinal perfusion, and in vivo animal models. 1 The intestinal absorption of a compound depends on 2 major parameters: 1) permeability across the epithelial mucosa and 2) gastrointestinal transit. Because gastrointestinal transit can be evaluated only in vivo, all in vitro systems can determine only mucosal permeability.
The main barrier for the absorption of a compound is formed by the intestinal epithelium, and several routes can be followed to cross this barrier. The passive transcellular pathway involves the movement of solute molecules across the apical membrane, through the cytoplasm, and across the basolateral membrane. This is the predominant route for hydrophobic compounds. Another passive route is via the tight junctions between the enterocytes: the paracellular pathway. Small hydrophilic compounds are mostly transported via the paracellular route. Finally, the intestinal mucosa expresses large numbers of transporters, which can enhance intestinal absorption (influx) or mediate the extrusion of compounds from the cell cytoplasm back to the intestinal lumen (efflux). Influx transporters increase intestinal absorption whereas efflux transporters have the opposite effect. For example, PEPT1 mediates the transport of di-and tri-peptides and peptidomimetic compounds such as β-lactam antibiotics. On the other hand, the efflux pump P-glycoprotein (or MDR1) is involved in the intestinal efflux of compounds such as the anticancer drug taxol.
This study analyzes the power of prediction of 3 in vitro models of human intestinal absorption: 1) the bio-mimetic artificial membrane permeability assay (BAMPA) method, which offers a highthroughput, noncellular approach to the measurement of passive transport. This method employs a phospholipid and cholesterol solution impregnated in a filter and analyzes the amount of compound that can translocate from one side to the other of the impregnated filter. 2) The more traditional 21-day Caco-2 cell assay, in which Caco-2 cells derived from human colon carcinoma cells are grown during 21 days to form a differentiated monolayer that resembles the intestinal lining. The use of this model as a highthroughput tool is limited by the long cell differentiation time (21 days) . 3) The BioCoat™ high-throughput screening (HTS) Caco-2 Assay System (BD Biosciences), which reduces Caco-2 cell differentiation to 3 days by modification of the cellular environment.
For the evaluation of these models, a set of 12 compounds with known human absorption values was selected ( Table 1 ). All these compounds have known human absorption percentages that cover a wide range of values. Similarly, different mechanisms of transport have also been considered. The objective of this study is to evaluate the power of prediction of these 3 methods, BAMPA, traditional Caco-2 monolayers of 21 days, and the BD BioCoat™ HTS Caco-2 Assay System from BD Biosciences that allows for fast differentiation (3 days) of Caco-2 cells.
MATERIALS AND METHODS

Materials
For the mix of phospholipids used for the BAMPA experiments, L-α-phosphatidylcholine, L-α-phosphatidylethanolamine, L-α-phosphatidylserine, and cholesterol were purchased from Sigma (St. Louis, MO). Phosphatidylinositol (from soybean) was obtained from Fluka (Buchs, Switzerland). The membrane mix solvent, 1,7-octadiene, was obtained at Aldrich. Multiscreen-IP for BAMPA and multiscreen PTFE acceptor plate were obtained from Millipore (Billerica, MA). Phosphate buffered saline (PBS; 1 mM KH 2 PO 4 , 10 mM Na 2 HPO 4 , 137 mM NaCl, and 2.7 mM KCl) was purchased from Roche Diagnostics (Mannheim, Germany).
For Caco-2 culture DMEM (with 4.5 g/L glucose and Lglutamine), fetal bovine serum (FBS) and penicillin/streptomycin solution (10,000 U/mL penicillin and 10,000 µg/mL streptomycin) were purchased from Bio-Whittaker Europe, Cambrex (Verviers, Belgium). The solution of nonessential amino acids was obtained at Gibco (Invitrogen Life Technologies, Breda, the Netherlands), as well as Hank's buffered salt solution (HBSS) without phenol red. BD Falcon HTS 24-Multiwell Insert System (1 µm pore size) with tray and BD Gentest Enhanced Recovery Plate were purchased from BD Biosciences (Bedford, MA).
BD BioCoat™ HTS Caco-2 Assay System from BD Biosciences (Bedford, MA) for the 3-day Caco-2 cell experiment contains all plates and reagents ready to use.
All compounds employed in the transport experiments (Table  1) as well as DMSO and 4-(2-hydroxyethyl)piperazine-1ethanesulfonic acid (HEPES) were obtained from Sigma. The 96well ultraviolet (UV) plates were from Corning (Schiphol-Rijk, the Netherlands).
BAMPA assay
To measure permeability by BAMPA, working solutions of each compound were prepared at a concentration of 150 µM in PBS at 3 different pH levels (7.4, 6.5, and 5.5) and 0.5% (v/v) DMSO. The acceptor plate was filled with 0.3 mL of PBS pH 7.4. The filter of the donor plate was impregnated with 5 µL of membrane mix. The mix of phospholipids reflected that of the gastrointestinal tract as has been described by Sugano 4, 5 : 0.8% (w/v) phosphatidylcholine, 0.8% (w/v) phosphatidylethanolamine, 0.2% (w/v) phosphatidylserine, 0.2% (w/v) phosphatidylinositol, and 1% (w/v) cholesterol in 1,7-octadiene. Immediately after the filter was impregnated with the membrane mix, the donor wells were filled with 0.2 mL of compound working solution in PBS and 0.5% (v/v) DMSO at the corresponding pH. The sandwich was constructed by placing the donor plate on top of the acceptor plate. This construct was placed in a plastic box together with some wetted tissue (to minimize evaporation). The plates were incubated for 16 h, after which concentrations were measured in the donor and acceptor wells and initial working solutions. For lucifer yellow, fluorescence was measured at the fluorometer Fusion α (PerkinElmer, Wellesley, MA) at excitation 485 nm and emission 530 nm. For the remaining compounds, samples of the donor and acceptor well solutions were transferred to a 96-well UV plate. Absorbance was measured between 200 and 500 nm using the plate reader SpectraMAX (Molecular Devices, Sunnyvale, CA).
Caco-2 cell culture
Caco-2 cells were grown in complete medium (DMEM, 20% [v/v] FBS, 0.2% [v/v] of a penicillin/streptomycin solution, and 1% [v/v] of a solution containing nonessential amino acids). Medium was changed every 2 to 3 days. Cells were cultured at 37°C and 5% CO 2 . For all experiments, cells were used between passages 40 and 60. 13 Passive Antihypertensive Lucifer yellow 6 0 None None
Human absorption values were obtained from previously reported values (see references for each compound). When the value was reported as a range, the median was used (parentheses indicate range).
Caco-2 cells: 21-day monolayers
Caco-2 cells were seeded into the wells of the Multiwell Insert System plate at a density of 3 × 10 5 cells/well. A volume of 25 mL of medium was added to the feeder tray. Cells were cultured for 21 days at 37°C and 5% CO 2 . During this time, the medium was changed every 2 to 3 days.
On the day of the experiment, working solutions of the compounds at 100 µM were prepared in transport buffer (HBSS and 25 mM HEPES) at pH 7.4 or 6.5 and 0.5% (v/v) DMSO. For the transport experiment, cells were washed with prewarmed transport buffer at the corresponding pH. To equilibrate the cells with the transport buffer, 0.31 mL of transport buffer were added to the wells. At the same time, the feeder tray was substituted for a 24well Enhanced Recovery Plate with 1 mL of transport buffer at pH 7.4. These plates are treated with a hydrophilic covalent coating to resist nonspecific adsorption of compounds. Then, cells were incubated for 25 min at 37°C and 5% CO 2 . After this time, transport buffer in the apical wells was removed and 0.31 mL of the corresponding compound working solution was added. The cells were placed again in the incubator for 2 h. Then the plates were separated, and concentrations were measured in the donor and acceptor wells and initial solution. For lucifer yellow, fluorescence was measured at the fluorometer Fusion α (PerkinElmer) at excitation 485 nm and emission 530 nm. For the rest of compounds, samples of donor and acceptor wells were transferred to a 96-well UV plate, and absorbance was measured between 200 and 500 nm.
Caco-2 cells: 3-day monolayers
For the BioCoat™ 3-day system, Caco-2 cells were seeded at 2 ×10 5 cells/insert in Basal Seeding Media containing MITO+ Serum Extender onto BioCoat™ Fibrillar Collagen Cell culture inserts (1 µm PET) and incubated for 24 h at 37°C and 5% CO 2 . Then media were changed to Entero-STIM Differentiation Media supplemented with MITO+ Serum Extender and incubated for 48 h. At this time, cells were rinsed twice in transport buffer and further analyzed. The transport experiment was performed as described for the 21-day Caco-2 monolayers.
Permeability calculation
From the concentration values measured in the donor and acceptor wells and the initial concentration of the working solutions used, permeability (P) values in cm/s were calculated using the following formula from Fick's Law:
where V is the volume of the acceptor well (0.3 mL and 1 mL for BAMPA and Caco-2 cells, respectively), A is the area of the insert (0.24 cm 2 and 0.31 cm 2 for BAMPA and Caco-2 cells, respectively), C i is the initial concentration of the compound (µM), C f is the final concentration of the compound in the acceptor well (µM), and t is the time in seconds (16 h = 57,600 s and 2 h = 7200 s for BAMPA and Caco-2 cells, respectively).
To predict human absorption, a correlation was created between permeability values and known human absorption values. 6 Sugano and others suggested the following equation 4, 7 :
where Fa is the percentage of absorption in humans, P measured permeability values, and a is a constant.
RESULTS
BAMPA assay
For each drug, 3 independent experiments were performed. The data for the complete drug set are indicated in Table 2 . From the data, we can observe that the diffusion of some drugs was strongly dependent on pH (such as warfarin, propranolol, furosemide, or naproxen), whereas for other compounds such as chloramphenicol, pH did not seem an influencing factor. As expected, cephalexin showed low permeability. Cephalexin, a β-lactam antibiotic, has a high human absorption because it is transported by the oligopeptide transporter PEPT1. BAMPA is an artificial membrane, and therefore no transporters or pores were present and cephalexin diffusion should remain low.
Using the permeability values obtained by BAMPA, a correlation to known human absorption could be performed. The results of the regression are indicated in Figure 1 . Cephalexin values were not included in the regression plot as cephalexin is a known substrate for active transport and therefore human absorption values were not reflected by BAMPA. The results show that the best correlation was obtained at pH 6.5 (Fig. 1B ). Correlation at pH 5.5 was very poor (Fig. 1C ).
Using the equation described in Figure 1B , the values of permeability obtained with BAMPA at pH 6.5 could be used to recalcu- late human absorption percentages. These predicted values were correlated with the known human percentages, so that the goodness of the fit can be visualized ( Fig. 2A ). For the calculation of the linear regression, the cephalexin value was not included. As seen in the graph, this value fell outside the 95% confidence range of prediction. This was expected, as cephalexin transport is dependent on the PEPT1 transporter. The slope of the regression curve should be close to 1 for an adequate fit between predicted and known values of human absorption. In this case, the slope was equal to 0.73. However, the prediction interval was quite wide. This might indicate that for some drugs, other factors could also influence absorption by passive diffusion. Factors such as pH, paracellular transport, or the effect of some transporters should also be taken into account.
Caco-2 cells: 21-day monolayers
Following the experiments described above, the permeability values obtained are shown in Table 3 . For each drug, the values are the mean of 3 independent experiments. For each experiment, each drug was tested in duplicate. Similarly as with BAMPA, the permeability of some compounds (such as warfarin or naproxen) depended on the pH of the donor solution. Interestingly, cephalexin permeability reached high values, similar to those observed for chloramphenicol or warfarin. The absorption of cephalexin is dependent on the presence of the oligopeptide transporter PEPT1. 8, 9 The results obtained with Caco-2 cells might be explained by assuming that this transporter was most probably present after 21 days of culture. These results are in agreement with others in which PEPT1 expression has been shown in Caco-2. 8, 10 In addition, cephalexin transport in both the intestine and Caco-2 cells has been shown to be directly proportional to PEPT1 expression. 9 On the other hand, norfloxacin permeability was lower than the expected human absorption (71%). It has been previously reported that there might be an efflux transporter present in Caco-2 cells that pumps back norfloxacin into the apical compartment. 11 The nature of this transporter has not been described so far.
The interpretation of the results of furosemide is somehow more complex. Furosemide absorption is the result of passive transport that has a significant paracellular component. 12 Moreover, furosemide is known to be a MDR1 substrate. 13 Consequently, furosemide transport is dependent on 3 variables. In the BAMPA experiments, furosemide was permeable, indicating that this compound can be absorbed by passive diffusion. In fact, using the equation described in Figure 1B , the prediction of human absorption for furosemide is 77% (the observed value is 61%). The human absorption prediction using the equation in Figure 3A (obtained with the Caco-2 21-day system) is 52%. This reduced value compared to the BAMPA model is indicative of the presence of and efflux pump in these cells (most probably MDR1). The Caco-2 predicted value is lower than that of the known human absorption. This could reflect the fact that 21-day Caco-2 cells show tighter pores than the intestinal mucosa and therefore underestimate the paracellular route. 2 The combination of all these factors can explain the results obtained.
With the permeability values obtained using 21-day Caco-2 monolayers, a correlation to known human absorption was also performed. The results of the regression are indicated in Figure 3 . Norfloxacin values were not included in the plot, as norfloxacin is a substrate for active efflux in Caco-2, and therefore human absorption values were not reflected. The strongest prediction was obtained at pH 7.4 (Fig. 3A) .
The prediction obtained with the Caco-2 21-day system at pH 7.4 was stronger that the one obtained by BAMPA at pH 6.5. As with BAMPA, using the equation described in Figure 3A , the values of permeability obtained with Caco-2 21-day monolayers at pH 7.4 were used to recalculate human absorption percentages (Fig. 2B) . The slope of the regression is 0.87, and the goodness of fit (r = 0.97) is also very good. This indicates that the Caco-2 21- day system is ideal for the prediction of human absorption. However, the presence of certain efflux pumps (that might not be present in the human intestinal tract or expressed at a lower level) can affect the prediction and needs be taken into consideration.
Caco-2 cells: 3-day monolayers
Results from these experiments are shown in Table 4 . The data indicate that even though the cell monolayers were fully formed, as shown by the low permeability of lucifer yellow, only the transport of very permeable compounds was detected. Compounds such as oxacillin, norfloxacin, or tetracycline, which have medium permeabilities, were not detected in the basolateral side. Moreover, cephalexin transport was also lower than expected. This might indicate that the transporter PEPT1 is not highly expressed in these cells. It could be possible that the differentiation was not fully completed or that the components of the medium prevented the expression of this and maybe other transporter(s).
The results shown in Figure 4 indicate that the best correlation (r = 0.94) was obtained at pH 6.5. Although the equation correlated well with the data obtained, such equations did not actually make much sense under the present study conditions. As shown in Figure 4B , most of the compounds were well absorbed or not absorbed at all. There were not intermediate values that could produce a wide range of human absorption prediction.
DISCUSSION
The prediction of human intestinal absorption is nowadays one of the bottlenecks in the discovery of active compounds. Ideally, a prediction method should be highly predictive, fast, reliable, costeffective, and require small amount of compound. 2,3 However, there is no definitive method that possesses all these characteristics. Every model has its advantages and disadvantages, and probably only the combination of different models can provide a more accurate prediction of human intestinal absorption. In this study, we have analyzed 3 models: 1) the BAMPA method, which offers a high throughput, noncellular approach to the measurement of passive diffusion; 2) the Caco-2 cell assay, the use of which as a high-throughput tool is limited by the long cell differentiation time (21 days); and 3) the BioCoat™ HTS Caco-2 Assay System (BD Biosciences), which reduces Caco-2 cell differentiation to 3 days.
Other systems such as Mardin-Darby canine kidney (MDCK) cells have not been analyzed in this study. These cells have been considered an alternative to Caco-2 for permeability measurements. 2, 14 Their main advantage is the shorter cell culture times (2-3 days). Several studies have found a good correlation between permeability coefficient values in Caco-2 and MDCK cells. 14 However, the canine kidney origin of MDCK cells is often considered a disadvantage. In addition, the expression of intestinal transporters in MDCK cells has not been well characterized and in some cases shows differences from those of Caco-2. 15 Irvine and others 14 suggested the MDCK cells as a useful tool for rapid membrane permeability screening, whereas Putnam and others 15 indicated that MDCK cells seem promising as a model of passive intestinal absorption. However, in both situations, the BAMPA method can provide faster results, particularly for the measurement of passive absorption.
The in vitro, high-throughput, noncellular assay for permeability screening of compounds, the so-called BAMPA, has been described by Sugano and others. 4, 5, 7 This method enables screening for permeability using artificial membranes in a 96-well microplate format. In the BAMPA assay, a sandwich is formed with a 96-well filter plate that matches a Teflon 96-well plate. The filter donor plate is placed on top on the Teflon acceptor plate, so that they define donor and acceptor compartments (top and bottom, respectively), separated by a microfilter disc. The microfilter disc is coated with membrane mix, a 1,7-octadiene solution of phospholipids and cholesterol with a composition that resembles that of the membrane of the enterocytes. Under these conditions, multilamellar bilayers form inside the filter pores when the system contacts an aqueous buffer solution. 1 The compound solution is applied at the top donor compartment. The rate of appearance in the acceptor compartment should reflect the diffusion across the lipid bilayer. Our results indicate that this method shows good correlation of permeability values obtained by BAMPA and absorption in humans. However, it has important disadvantages, mainly the lack of active transporters and pores. BAMPA does not contain enzymes, influx and efflux transporters, and pores that reflect active and the paracellular pathways in intestinal absorption and therefore can render false negatives. This was reflected in the low permeability of cephalexin, a β-lactam antibiotic that is transported in humans by PEPT1, absent in BAMPA. Moreover, the effect on absorption of some factors such as paracellular transport or the presence of some transporters is underestimated in the prediction obtained with BAMPA. However, this method might still be useful for HTS and for mechanistic experiments, such as pH profiling. Cell culture models for drug absorption are based on the assumption that the passage of compounds across the intestinal epithelium (a monolayer of cells) is the main barrier for compounds to reach the portal circulation. In vivo, the enterocytes make up 90% of the cells in the epithelium and are responsible for the majority of absorptive functions. 1 Enterocytes are highly polarized cells, in which the apical surface faces the intestinal lumen and the basolateral surface faces the bloodstream. The apical surface presents an extensive brush border, and it contains numerous digestive enzymes such as aminopeptidase and alkaline phosphatase.
Caco-2 cells, which are derived from human colonic adenocarcinoma, exhibit morphological as well as functional similarities to intestinal enterocytes. These cells were first characterized in 1977 16 and have been used extensively as an intestinal permeability model since 1990. 2 The cells form tight junctions and an apical brush border membrane with microvilli and express many intestinal enzymes (aminopeptidases, esterases, PEPT1, pglycoprotein, etc. 2, 15, 17 ). This degree of differentiation has resulted in Caco-2 cells' becoming one of the most popular cell culture models to study intestinal absorption.
For experimental studies, Caco-2 cells are grown for 21 days to form differentiated monolayers on a porous permeable filter (generally made of polycarbonate). This 21-day culture is required to obtain tight junctions, cell polarity, and high expression of efflux mechanisms such as P-glycoprotein. 17, 18 For transport experiments described in this article, the compound was added to the apical side of the monolayer, and appearance in the basolateral side was measured after 2 h. In general, Caco-2 monolayers are considered to be a good model for the prediction of human intestinal absorption. 19 Our results indicate that Caco-2 monolayers grown over 21 days have the strongest power of prediction of human intestinal absorption, particularly when transport experiments are performed at pH 7.4. The main disadvantage of this method is the long culture time (21 days) and the corresponding consuming care and handle of cells during this time. Moreover, in this format, the number of compounds that can be analyzed is not very high (only 24 wells per plate). There are now available in the market 96-well plates for Caco-2 transport studies from BD Biosciences and Millipore. Data on these plates have not been included, but first-hand experience indicates that the handling and the maintenance of an intact monolayer become more difficult due to the reduced working area.
The optimal pH for transport experiments in 21-day Caco-2 monolayers is 7.4. However, the pH of the intestinal mucosa is not 7.4, but around 6 to 6.5. One must consider that Caco-2 cells are always grown in physiological medium, which is at pH 7.4. In other words, they have been preselected to perform more efficiently at pH 7.4 and not at pH 6.5. This can explain the difference in optimal pH observed with Caco-2 cells and the optimal BAMPA prediction at pH 6.5 (which probably reflects to a better degree that of the intestinal mucosa).
When used for screening purposes, the major bottlenecks experienced in Caco-2 permeability experiments are 1) the 21-day culture time, 2) the labor-intensive handling of the cells, and 3) the analysis of a large number of samples. 1 To solve these problems and to lower cell culture time, a modified culture system, namely, the BD BioCoat™ HTS Caco-2 Assay System from BD Biosciences, has been marketed. Fast growth of Caco-2 cells is obtained by altering the filter supports, the filter coating, and the cell culture medium. Even the barrier function of these monolayers is low compared to the traditional 21-day culture; it has been claimed that permeability coefficients across this monolayer correlate reasonably well with the extent of absorption in man. 20, 21 However, our results indicate that the BioCoat™ HTS Caco-2 Assay System does not seem to be adequate for the prediction of human absorption. The regression at pH 7.4 is not satisfactory, whereas at pH 6.5, it has no biological significance, as the curve cannot predict any intermediate values of human absorption. These results are not in agreement with those obtained by Chong and others 20 and Yamashita and others. 21 Both studies employ high-performance liquid chromatography and/or liquid scintillation to determine compound concentration, which are more sensitive methods than UV/vis spectrophotometry for the measurement of compound concentration. This can explain their better results for compounds with low permeability. However, it should be indicated that Chong and others 20 employed 6-well plates, which probably also help in the measurement of compounds with low permeability due to the increased surface area. Moreover, Yamashita and others 21 analyzed different culture variants and concluded that an extended 5-day culture protocol produced much better transporter activities.
We therefore believe that this accelerated 3-day method is not ideal for screening. It is possible that the ingredients used in the cell culture media to accelerate the differentiation are not adequate for the full differentiation and functionality of the cells. Further development should be considered for this system, such as increased culture period and more sensitive analysis methods.
The combination of BAMPA and 21-day Caco-2 monolayers is of great interest. BAMPA can handle a large number of compounds in an easy and fast manner. Even during screening, some compounds might be lost as false negatives and a certain number of hits can be obtained with a good degree of predictability. These hits can be further reanalyzed using the traditional Caco-2 method that performs with better accuracy.
The combination of the information obtained with the BAMPA and Caco-2 21-day system can provide valuable information in the prediction of the mechanism of transport. By building a correlation between the predicted values obtained with Caco-2 and BAMPA, a confidence margin of 95% prediction can be obtained (Fig. 2C) . For compounds whose combined values fall inside this margin, it can be concluded that they are absorbed mainly via passive diffusion. For those substances in which the combined values fall in the prediction interval (when BAMPA predicted values are low but Caco-2 values are high; see cephalexin in Fig. 2C ), it can be concluded that an active mechanism is responsible for the transport. On the other hand, when the BAMPA value is high and the Caco-2 value is low (see norfloxacin in Fig. 2C ), it can be deduced that an active efflux pump can affect the transport of the compound.
Slight deviations from the predicted passive diffusion pathway of absorption can sometimes be explained. For example, it has been shown that theophylline is absorbed via passive diffusion. 22 However, its presence can affect the paracellular pathway, as it increases the pore size. This can explain the intermediate predicted absorption obtained in the BAMPA experiment and the high predicted absorption in the Caco-2 experiment. In this last situation, theophylline might affect the pores in the monolayer, opening a 2nd route for its transport.
CONCLUSIONS
When screening for a large number of compounds, BAMPA is an adequate system for the prediction of human absorption. This method is fast and simple and therefore perfect for handling a large number of samples. Although some compounds (those that would be transported through an active mechanism or via the paracellular route) might be excluded, it would still be valid to detect compounds absorbed by passive diffusion.
Compounds positive for absorption in the BAMPA assay can be reanalyzed by the Caco-2 21-day method to confirm the result, exclude the action of efflux pumps, and obtain a more accurate prediction. When handling a small number of compounds or when a better prediction is needed, Caco-2 cells grown for 21 days should be the system of choice. This method does not allow the fast handling of a large number of samples but provides a more accurate prediction of human absorption. When it is necessary to know the mechanism of transport of a specific substance, then performing both methods (BAMPA and Caco-2 21-days) becomes ideal.
